Govt mulls alternate ways for drug price control

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 10:54 PM IST

The government is planning a back-door route to bring more drugs under price control as the proposed National Pharmaceutical Policy seems unlikely to materialise in the near future.

"As there is uncertainty about the fate of Pharmaceutical Policy, the government is looking for other alternatives for bringing more drugs under the preview of price control," a senior government official told PTI.

Other alternatives include, amending Drug Price Control Order (DPCO) 1995, expanding national list of essential medicines and bringing more medicines under the category of scheduled drugs, the official said.

The move is unlikely to face resistance from the Health Ministry, which had earlier raised objections to certain provisions of proposed draft of the National Pharmaceutical Policy 2006.

The draft policy prepared by the Chemicals Ministry sought to expand the ambit of National List of Essential Medicines (NLEM) from 74 to 354 by bringing more drugs under price control.

It had evoked a sharp reaction from the industry which argued that it would adversely affect research and development activities in India as companies would stay away from investing in new drugs.

The draft policy was referred to a Group of Ministries (GoM) by the Cabinet in January 2007. Even after four meetings in last two years, the GoM under the chairmanship of Agriculture Minister Sharad Pawar has not been able to resolve the deadlock.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 16 2008 | 6:11 PM IST

Next Story